Impact of Generic Substitution Practice on Care of Diabetic Patients

Overview

Journal Int J Clin Pharm

Publisher Springer

Specialties Pharmacology
Pharmacy

Date 2014 Apr 11

PMID 24718947

Citations 2

Authors

Olubukola O Oyetunde

Bolajoko A Aina

Fola Tayo

Affiliations

Soon will be listed here.

Abstract

Background: Patients with chronic diseases like type II diabetes mellitus often have their prescriptions substituted with generic medicines in the course of care to save costs of medicines and to improve access. There is need to assess impact of this practice on patient care.

Objective: To assess patient's knowledge of generic substitution practice and its impact on patient care.

Setting: An outpatient diabetic clinic of a tertiary hospital in Nigeria.

Method: The study is a cross sectional survey of patients attending a diabetic clinic. A structured questionnaire was used to interview willing patients. A total of 120 patients were enrolled for the study, but only 102 responded (85 % overall response rate).

Main Outcome Measures: Patients' knowledge of generic substitution practice, patients' report of abstaining from drug use, experiences of more side effects and patients' confusion.

Results: Over half (57.8 %) of surveyed patients (n = 59) had noticed brand switches, out of which, 30.5 % experienced brand switches more than 3 times within a year. More than a third of the respondents (38.6 %) did not know when pharmacists actually substituted their medicines. About one in five (19.6 %) patients did not use their medicines after substitution because they were not sure of the brand supplied but 35.6 % have rejected substitution at one time and insisted on doctors' prescription. Respondents (14.9 %) agreed that brand substitution resulted in confusion while 24 % reported receiving brands that resulted in more side effects. More respondents (58.6 %) indicated that they never had a discussion with their pharmacists about the reasons for generic substitution and switches.

Conclusion: Generic substitution without adequate information resulted in confusion and subsequent lack of adherence. There is the vital need for appropriate policy and guidelines for generic substitution in Nigeria.

Citing Articles

Self-management of diabetes in Sub-Saharan Africa: a systematic review.

Stephani V, Opoku D, Beran D BMC Public Health. 2018; 18(1):1148.

PMID: 30268115 PMC: 6162903. DOI: 10.1186/s12889-018-6050-0.

Sustainability in Health care by Allocating Resources Effectively (SHARE) 10: operationalising disinvestment in a conceptual framework for resource allocation.

Harris C, Green S, Elshaug A BMC Health Serv Res. 2017; 17(1):632.

PMID: 28886740 PMC: 5590199. DOI: 10.1186/s12913-017-2506-7.

References

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

Heikkila R, Mantyselka P, Hartikainen-Herranen K, Ahonen R . Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2006; 82(3):366-74. DOI: 10.1016/j.healthpol.2006.10.006. View

Simmenroth-Nayda A, Hummers-Pradier E, Ledig T, Jansen R, Niebling W, Bjerre L . [Prescription of generic drugs in general practice. Results of a survey of general practitioners]. Med Klin (Munich). 2006; 101(9):705-10. DOI: 10.1007/s00063-006-1097-6. View

Ganther J, Kreling D . Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc (Wash). 2000; 40(3):378-83. DOI: 10.1016/s1086-5802(16)31086-5. View

Hakonsen H, Toverud E . Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway. Eur J Clin Pharmacol. 2010; 67(2):193-201. PMC: 3021708. DOI: 10.1007/s00228-010-0960-9. View

. American Academy of Pediatrics Committee on Drugs: Generic prescribing, generic substitution, and therapeutic substitution. Pediatrics. 1987; 79(5):835. View

Ganther-Urmie J, Nair K, Valuck R, McCollum M, Lewis S, Turpin R . Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans. Am J Manag Care. 2004; 10(3):201-8. View

Johnston A, Asmar R, Dahlof B, Hill K, Jones D, Jordan J . Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe. Br J Clin Pharmacol. 2011; 72(5):727-30. PMC: 3243005. DOI: 10.1111/j.1365-2125.2011.03987.x. View

. Generic Drugs. Med Lett Drugs Ther. 2002; 44(1141):89-90. View

10.

Uloko A, Ofoegbu E, Chinenye S, Fasanmade O, Fasanmade A, Ogbera A . Profile of Nigerians with diabetes mellitus - Diabcare Nigeria study group (2008): Results of a multicenter study. Indian J Endocrinol Metab. 2012; 16(4):558-64. PMC: 3401756. DOI: 10.4103/2230-8210.98011. View

11.

Holmes Jr D, Becker J, Granger C, Limacher M, Page 2nd R, Sila C . ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee. Circulation. 2011; 124(11):1290-310. DOI: 10.1161/CIR.0b013e31822d97d5. View

12.

Antoni Valles J, Barreiro M, Cereza G, Ferro J, Martinez M, Escriba J . A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy. 2003; 65(3):269-75. DOI: 10.1016/s0168-8510(03)00018-6. View

13.

Steinman M, Chren M, Landefeld C . What's in a name? Use of brand versus generic drug names in United States outpatient practice. J Gen Intern Med. 2007; 22(5):645-8. PMC: 1852907. DOI: 10.1007/s11606-006-0074-3. View

14.

Hassali M, Shafie A, Jamshed S, Ibrahim M, Awaisu A . Consumers' views on generic medicines: a review of the literature. Int J Pharm Pract. 2010; 17(2):79-88. View

15.

Chong C, March G, Clark A, Gilbert A, Hassali M, Bahari M . A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2010; 99(2):139-48. DOI: 10.1016/j.healthpol.2010.08.002. View

16.

Kalisch L, Roughead E, Gilbert A . Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia. Pharmacoepidemiol Drug Saf. 2008; 17(6):620-5. DOI: 10.1002/pds.1580. View

17.

Garattini L, Tediosi F . A comparative analysis of generics markets in five European countries. Health Policy. 2000; 51(3):149-62. DOI: 10.1016/s0168-8510(00)00061-0. View

18.

Fairman K, Curtiss F . The elephant in the pharmacy: patient choice is the big challenge that no one talks about in affordability of prescription drugs. J Manag Care Pharm. 2007; 13(7):620-2. PMC: 10437725. DOI: 10.18553/jmcp.2007.13.7.620. View

19.

Wilner A . Physicians underestimate the frequency of generic carbamazepine substitution: results of a survey and review of the problem. Epilepsy Behav. 2003; 3(6):522-525. DOI: 10.1016/s1525-5050(02)00527-9. View

20.

Reichert S, Simon T, Halm E . Physicians' attitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med. 2000; 160(18):2799-803. DOI: 10.1001/archinte.160.18.2799. View